2021-01888. Advisory Board on Radiation and Worker Health (ABRWH), Subcommittee on Dose Reconstruction Review (SDRR), National Institute for Occupational Safety and Health (NIOSH); Correction

Notice is hereby given of a change in the meeting of the Advisory Board on Radiation and Worker Health (ABRWH), Subcommittee on Dose Reconstruction Review (SDRR), National Institute for Occupational Safety and Health (NIOSH); February 25, 2021, 10:30 a.m. to 2:30 p.m., EST which was published in the Federal Register on December 23, 2020, Volume 85, Number 247, pages 83965-83966.

The Matters to be Considered should read as follows:

SUPPLEMENTARY INFORMATION:

Matters to be Considered: The agenda will include discussions on the following dose reconstruction program quality management and assurance activities: Dose reconstruction cases under review from Set 28, possibly including cases involving, Rocky Flats Plant (RFP), Hanford, Los Alamos National Laboratory (LANL), Mound, Lawrence Livermore National Laboratory (LLNL), Savannah River Site (SRS), Oak Ridge National Laboratory (X-10), and Y-12 Plant. Dose reconstruction cases under review from Sets 14 through 21, possibly including cases involving, Uranium Mill in Monticello, GE Vallecitos, and Texas City Chemicals; and Tracking of decision points requiring professional judgement (time permitting). Agenda items are subject to change as priorities dictate.

FOR FURTHER INFORMATION CONTACT:

Rashaun Roberts, Ph.D., Designated Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C-24, Cincinnati, Ohio 45226, Telephone [phone], Toll Free 1 (800) CDC-INFO, Email [e-mail].

The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,

Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.